iPierian Announces Oral Presentation of Tau Antibody Preclinical Efficacy Study Which Showed Significant Reduction in Alzheimer’s Disease Progression

Business Wire
iPierian Announces Oral Presentation of Tau Antibody Preclinical Efficacy Study Which Showed Significant Reduction in Alzheimer’s Disease Progression
 
View Comments (0)

Recommended for You